Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Aevi Genomic Medicine (GNMX)

1.67 -0.03 (-1.76%)

05-22 16:00

Open:

1.8

Pre. Close:

1.7

High:

1.7

Low:

1.6368

Volume:

108,397

Market Cap:

99M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.801 - 1.811

1.811 - 1.816

Low:

1.62 - 1.631

1.631 - 1.638

Close:

1.654 - 1.671

1.671 - 1.682

Technical analysis  (as of: 2018-05-22 4:39:26 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 2.10     One year: 2.46

Support:

Support1: 1.53    Support2: 1.36

Resistance:

Resistance1: 1.80    Resistance2: 2.10

Pivot:

1.57

Moving Averages:

MA(5): 1.63     MA(20): 1.56

MA(100): 1.78     MA(250): 1.50

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 77.02     %D(3): 79.37

RSI:

RSI(14): 54.65

52-Week:

High: 2.65  Low: 0.98  Change(%): 30.5

Average Vol(K):

3-Month: 8427  10-Days 8536

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GNMX has closed below upper band by 10.7%. Bollinger Bands are 46.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNMX's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-20T10:31:09-04:00
Aevi Genomic Medicine: Try Subgroups Until It Works?

2018-05-15T09:01:55-04:00
Aevi Genomic down 6% on Q1 result

2018-05-15T08:41:55-04:00
Aevi Genomic reports Q1 results

2018-05-15T08:30:00-04:00
Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

2018-04-30T09:35:00-04:00
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

2018-04-29T18:56:00-04:00
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

2018-03-29T13:02:35-04:00
Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

2018-03-20T08:00:00-04:00
Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

59.34

Shares Float (M)

52.16

% Held by Insiders

12.10

% Held by Institutions

47.20

Shares Short (K)

369

Shares Short Prior Month (K)

373

Stock Financials

EPS

-0.870

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.750

EPS Est. Next Quarter

-0.160

Forward EPS

-0.660

Book Value (p.s.)

2.910

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-92.2

Return on Equity (ttm)

-105.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.463

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.25

Levered Free Cash Flow (M)

-20.23

atoplab.com

Valuation

P/E

-1.92

P/E Growth Ratio

-0.02

P/BV

0.57

P/S

P/CF

-2.98

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.